James F. Dropinski
Merck & Co., Inc., Rahway, NJ, USA (United States)(US)
Publications by Year
Research Areas
Peroxisome Proliferator-Activated Receptors, Antifungal resistance and susceptibility, Crystallization and Solubility Studies, X-ray Diffraction in Crystallography, Chemical Synthesis and Analysis
Most-Cited Works
- → In vitro preclinical evaluation studies with the echinocandin antifungal MK-0991 (L-743,872)(1997)312 cited
- → Evaluation of the echinocandin antifungal MK-0991 (L-743,872): efficacies in mouse models of disseminated aspergillosis, candidiasis, and cryptococcosis(1997)244 cited
- → Chemistry informer libraries: a chemoinformatics enabled approach to evaluate and advance synthetic methods(2016)240 cited
- → A multifunctional catalyst that stereoselectively assembles prodrugs(2017)183 cited
- → Preliminary animal pharmacokinetics of the parenteral antifungal agent MK-0991 (L-743,872)(1997)167 cited
- → Oxyfunctionalization of the Remote C−H Bonds of Aliphatic Amines by Decatungstate Photocatalysis(2017)164 cited
- → Efficacy of MK-991 (L-743,872), a Semisynthetic Pneumocandin, in Murine Models of Pneumocystis carinii(1998)126 cited
- → Synthesis and Antifungal Activity of Novel Cationic Pneumocandin Bo Derivatives(1994)112 cited
- → Novel 2,3-Dihydrobenzofuran-2-carboxylic Acids: Highly Potent and Subtype-Selective PPARα Agonists with Potent Hypolipidemic Activity(2005)99 cited
- → Design and Synthesis of α-Aryloxyphenylacetic Acid Derivatives: A Novel Class of PPARα/γ Dual Agonists with Potent Antihyperglycemic and Lipid Modulating Activity(2005)77 cited